Subscribe To
Cassava Sciences to Present at the 2023 H.C. Wainwright Investor Conference
AUSTIN, Texas, April 26, 2023 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced that Remi Barbier, President & Chief Executive Officer, has been invited to present at the 2023 H.C. Wainwright BioConnect Investor Conference in New York. In addition, management will be available for one-on-one […] The post Cassava Sciences to Present at the 2023 H.C. Wainwright Investor Conference appeared first on Forex...
Read More
Posted: Apr 26 2023, 13:12
Author Name: forextv
Views: 102241